Effect of a novel phosphodiesterase type 5 inhibitor, CPD1, on carbon tetrachloride-induced liver fibrosis in mice

Wen-Bin FENG; Jian-Qin YANG; Xin-Hui CHEN; Zhong-Lian XIE; Ying-Ying ZHANG; Ying-Xi CHEN; Zi-Jian ZHAO; Yun-Ping MU; Fang-Hong LI.
Chinese Pharmacological Bulletin ; (12): 470-476, 2023.
Artículo en Zh | WPRIM | ID: wpr-1013838

Documentos relacionados

  1. Effect of mycophenolate mofetil alleviates carbon tetrachloride-induced liver fibrosis in mice.
  2. [Changes in the activities of antigen-nonspecific helper and suppressor cells in rabbits after carbon tetrachloride-induced liver damage].
  3. [An experimental study of the hepatoprotective properties of phytoecdysteroids and nerobol in carbon tetrachloride-induced liver lesion].
  4. [Effectiveness of vitamin E and sodium selenate in carbon tetrachloride-induced liver damage depending on the season].
  5. [Carbon tetrachloride-induced nephropathy].
  6. CD14 is not required for carbon tetrachloride-induced hepatic inflammation and fibrosis with or without lipopolysaccharide challenge.
  7. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
  8. Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways.
  9. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
  10. Mediator subunit MED1 deficiency prevents carbon tetrachloride-induced hepatic fibrosis in mice.